SCHEMBL20988415

SCHEMBL20988415

CC(C)(C)NC(=O)c1csc(-c2ccc(C(F)(F)F)cc2)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.64
LMNA P02545 2/20 0.64
MAPT P10636 2/20 0.64
TLR7 Q9NYK1 2/20 0.63
NR1H4 Q96RI1 1/20 0.57
IDE P14735 1/20 0.55
MAPK10 P53779 1/20 0.55
HPGD P15428 1/20 0.53
ALDH1A1 P00352 1/20 0.53
RAB9A P51151 2/20 0.52
POLB P06746 2/20 0.52
NPC1 O15118 1/20 0.52
ROCK2 O75116 1/20 0.52
ROCK1 Q13464 1/20 0.52
GAA P10253 1/20 0.51
KDM4E B2RXH2 2/20 0.50
HDAC1 Q13547 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20988323 0.86 HPGD (0.71) MAPK1LMNAMAPTTLR7IDE
SCHEMBL2546011 0.84 ALDH1A1 (0.73) MAPK1LMNAMAPTTLR7NR1H4
SCHEMBL20988413 0.83 HDAC1 (0.68) LMNAMAPTTLR7HPGDALDH1A1
SCHEMBL15896523 0.82 MAPK1 (0.60) MAPK1LMNAMAPTTLR7NR1H4
SCHEMBL20988338 0.82 TLR7 (0.63) LMNAMAPTTLR7HPGDALDH1A1
SCHEMBL3533598 0.80 ALDH1A1 (0.65) MAPK1LMNAMAPTTLR7NR1H4
SCHEMBL27966345 0.80 MAPK1 (0.59) MAPK1LMNAMAPTTLR7NR1H4
SCHEMBL3063332 0.79 LMNA (0.64) MAPK1LMNAMAPTTLR7NR1H4
SCHEMBL20988414 0.79 MAPK1 (0.60) MAPK1LMNAMAPTTLR7NR1H4
SCHEMBL15893970 0.78 MAPK1 (0.56) MAPK1LMNAMAPTTLR7NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10654802-B2 Indoline derivatives and method for using and producing the same ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNVERSIT (US) 2020-05-19 US disclosed
US-20190135746-A1 INDOLINE DERIVATIVES AND METHOD FOR USING AND PRODUCING THE SAME ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNVERSITY OF ARIZONA 2019-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10654802-B2 Indoline derivatives and method for using and producing the same IDO1, IDO2, MMP1 MAPK1 2548/4885LMNA 1162/4885MAPT 1971/4885
US-20190135746-A1 INDOLINE DERIVATIVES AND METHOD FOR USING AND PRODUCING THE SAME IDO1, INMT, MMP1 MAPK1 2676/4885LMNA 1099/4885MAPT 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.